Are peptides legal in Idaho?

Can a Idaho resident get peptides by telehealth?

Idaho Code 54-5705, amended in 2025, lets a provider deliver virtual care when the provider or the provider's group already has a relationship with the patient, is covering calls for a provider who does, or first establishes a relationship, and states that a provider-patient relationship may be established by use of virtual care technologies provided the applicable Idaho community standard of care is satisfied (earlier versions required two-way audio and visual interaction to form the relationship). The act requires the provider to obtain and document relevant clinical history and current symptoms before issuing a prescription drug order, and states that treatment based solely on a static online questionnaire does not meet the standard of care. Prescribing by virtual care is allowed within the provider's scope of practice; controlled substances must comply with federal law. Because the relationship may now be formed through any virtual care technology that meets the standard of care, an asynchronous evaluation that is more than a static questionnaire can support a non-controlled prescription. Idaho Code 54-5713 (added 2023) requires a provider to hold a license from the applicable Idaho board before delivering virtual care, with narrow exceptions for a provider licensed in another state who already has a relationship with a patient temporarily in Idaho, is giving short-term follow-up for continuity of care, is employed by or contracted with an Idaho facility, is responding to a disaster, is preparing for a scheduled in-person visit, or is consulting with or referring to an Idaho-licensed provider. A direct-to-consumer telehealth program run from another state generally fits none of these exceptions, so its prescriber needs an Idaho license, and an exempt provider consents to Idaho law, the Idaho community standard of care, and Idaho board jurisdiction. [2] [3] [5]

How does the Idaho pharmacy board treat compounding?

The Idaho State Board of Pharmacy, administered by the Division of Occupational and Professional Licenses, regulates compounding under the Idaho Pharmacy Act (Idaho Code Title 54, Chapter 17). In 2025, House Bill 200 moved the Board's rules into statute and IDAPA 24.36.01, including its former compounding section 24.36.01.700, ceased to have effect on July 1, 2025. Compounding standards now sit in Idaho Code 54-1765 through 54-1767: section 54-1765 treats any compounding it does not permit as manufacturing, requires active ingredients from an FDA registered manufacturer with a certificate of analysis unless the ingredient meets a USP-NF monograph, prohibits compounding drugs FDA has identified as demonstrably difficult to compound or withdrawn from the market, limits copies of commercially available products, and requires policies that take into account USP chapters 795 and 797; section 54-1766 covers sterile preparation. Idaho's pharmacy law is shorter than most, but eligibility of a peptide for compounding still follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). Under Idaho Code 54-1729, every drug outlet doing business in or into Idaho must be licensed or registered, a nonresident pharmacy must be licensed in good standing in its home state with a registered person in charge, and the Board may inspect a nonresident outlet at the outlet's expense if its home state will not. [1] [4] [6] [7] [8] [9]

Can you get compounded GLP-1s in Idaho?

Branded Wegovy, Zepbound, Ozempic, and Mounjaro are available from Idaho pharmacies by prescription, and Idaho's virtual care law makes remote prescribing straightforward when the standard of care is met. Patients should confirm an out-of-state pharmacy is registered as a nonresident drug outlet with the Idaho Board. [2] [4] [12]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Idaho?

Find a provider in Idaho

• Compounding pharmacies in Idaho
• Clinics in Idaho
• Telehealth providers in Idaho

Is it legal to buy research peptides in Idaho?

Idaho Code 54-1729 requires every drug outlet doing business in or into Idaho to be licensed or registered with the Board of Pharmacy. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling, are not dispensed by a pharmacist, and do not become lawful because Idaho's pharmacy rules are comparatively light. [4] [13]

Peptide-specific notes for Idaho

Frequently asked questions

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.